Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System

Daobin Wu, Rongying Yang, Jun Zeng, Zhou Bai, Chunda Zhang, Xinrong Fan, Xiangyu Zhou, Lin Wu, Sui Zhu, Ibrahim Akin, Xiaobo Zhou, Lijia Chang, Kenji Hashimoto, Yan Wei

Open source

DOI
10.1007/s00210-026-06025-x
Published
2026-11-06
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-06025-x,
  title = {Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System},
  author = {Daobin Wu and Rongying Yang and Jun Zeng and Zhou Bai and Chunda Zhang and Xinrong Fan and Xiangyu Zhou and Lin Wu and Sui Zhu and Ibrahim Akin and Xiaobo Zhou and Lijia Chang and Kenji Hashimoto and Yan Wei},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-06025-x},
  url = {https://doi.org/10.1007/s00210-026-06025-x}
}

RIS

TY  - JOUR
TI  - Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System
AU  - Daobin Wu
AU  - Rongying Yang
AU  - Jun Zeng
AU  - Zhou Bai
AU  - Chunda Zhang
AU  - Xinrong Fan
AU  - Xiangyu Zhou
AU  - Lin Wu
AU  - Sui Zhu
AU  - Ibrahim Akin
AU  - Xiaobo Zhou
AU  - Lijia Chang
AU  - Kenji Hashimoto
AU  - Yan Wei
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-06025-x
UR  - https://doi.org/10.1007/s00210-026-06025-x
ER  - 

APA

Wu, D., Yang, R., Zeng, J., Bai, Z., Zhang, C., Fan, X., Zhou, X., Wu, L., Zhu, S., Akin, I., Zhou, X., Chang, L., Hashimoto, K., & Wei, Y. (2026). Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06025-x

Source records